Transurethral prostatectomy remains the most efficacious method of treating symptomatic benign prostatic hyperplasia and has been termed the 'gold standard'. However, significant morbidity such as bleeding and transurethral syndrome is associated with the transurethral prostatectomy. With simple application of known electrosurgical principles, the desired effects of the transurethral prostatectomy can be achieved without these morbidities. This review focuses on this technique, transurethral electrovaporization of the prostate, which combines electrosurgical vaporization and desiccation to surgically treat benign prostatic hyperplasia. The technique is simple, hemostatic, does not produce a transurethral syndrome, and uses currently available equipment. Basic electrosurgical theory, transurethral electrovaporization of the prostate equipment, technique and clinical experience with transurethral electrovaporization of the prostate will be discussed.
展开▼
